Obagi Skintrinsiq Clarifiying Protocol
- Product NDC
- 62032-909
- 11-digit product format
- 620320909
- Labeler code
- 62032
- Product ID
- 62032-909_a9c17c57-a3af-43d6-9db3-56fb8e28894b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- salicylic acid, titanium dioxide, and zinc oxide
- Dosage form
- KIT
- Labeler
- Obagi Cosmeceuticals LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-01
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Obagi Skintrinsiq Clarifiying Protocol
- Listing expiration
- 2026-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08ba9ea8-73fd-472b-9cc4-67df167352ec | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2025-04-01 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2025-01-30 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2023-03-29 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2023-01-30 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-612-04 | Obagi Skintrinsiq Clarifiying Protocol | 148 mL in 1 BOTTLE, PLASTIC | LIQUID | 148 mL | 20 mg in 1mL | 3 |
| 62032-811-09 | Obagi Skintrinsiq Clarifiying Protocol | 1 in 1 CARTON | LOTION | 15.6 g in 100g | 3 | |
| 62032-811-09 | Obagi Skintrinsiq Clarifiying Protocol | 85 g in 1 TUBE | LOTION | 85 g | 15.6 g in 100g | 3 |
| 62032-909-09 | Obagi Skintrinsiq Clarifiying Protocol | 1 in 1 BOX | KIT | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62032-909 | OBAGI SKINTRINSIQ CLARIFIYING PROTOCOL (SALICYLIC ACID, TITANIUM DIOXIDE, AND ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250406_08ba9ea8-73fd-472b-9cc4-67df167352ec.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mineral Sunscreen Zinc Oxide | ZINC OXIDE | Hirschman, Kristina | 35bb9341-355f-4910-e063-6294a90a8c15 | 2025-12-10 | M020 | |
| Tinted Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Hirschman, Kristina | 35bd61ff-0d66-a9b3-e063-6394a90ad940 | 2025-12-10 | M020 | |
| SHADED | TITANIUM DIOXIDE, ZINC OXIDE | Potency No. 710 LLC | 31177bbd-68b0-8b24-e063-6294a90aa8d8 | 2025-12-10 | Warnings | M020 |
| SHADED | TITANIUM DIOXIDE, ZINC OXIDE | Potency No. 710 LLC | 3117e138-83a1-0931-e063-6394a90abe43 | 2025-12-10 | Warnings | M020 |
| SHADED | TITANIUM DIOXIDE, ZINC OXIDE | Potency No. 710 LLC | 31188175-a4ca-449f-e063-6394a90a3c05 | 2025-12-10 | Warnings | M020 |
| COVERED | ZINC OXIDE | Potency No. 710 LLC | 3118c3ed-f0f0-f997-e063-6294a90a53a9 | 2025-12-10 | Warnings | M020 |
| COVERED | ZINC OXIDE | Potency No. 710 LLC | 3117faeb-1792-1b2e-e063-6294a90a92df | 2025-12-10 | Warnings | M020 |
| Non-Tinted Mineral Foaming Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Restore Skin Therapy, LLC | 364b6af2-a0ed-4a17-e063-6394a90a3a17 | 2025-12-10 | M020 | |
| Morning Replenish | ZINC OXIDE | Restore Skin Therapy, LLC | 364b26c2-a1bb-9660-e063-6294a90a14d1 | 2025-12-10 | M020 | |
| Glass Skin Sunscreen Tinted | ZINC OXIDE | Fleur de Lune, LLC | 34288989-35b8-3aa3-e063-6394a90ac2c4 | 2025-12-10 | M020 | |
| Glass Skin Sunscreen Tinted | ZINC OXIDE | Fleur de Lune, LLC | 3418394b-fede-65ce-e063-6394a90ad5f9 | 2025-12-10 | M020 | |
| Glass Skin Sunscreen Non-Tinted | ZINC OXIDE | Fleur de Lune, LLC | 341871e5-c170-7560-e063-6394a90a8eee | 2025-12-10 | M020 | |
| Glass Skin Sunscreen Non-Tinted | ZINC OXIDE | Fleur de Lune, LLC | 3428bdbb-1f18-a29b-e063-6294a90addbc | 2025-12-10 | M020 | |
| Sheer Facial Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | BB MEDICAL & DERMATOLOGY INC | 342b2403-4f4a-3e77-e063-6294a90a4f0a | 2025-12-10 | M020 | |
| Sheer Mineral Sunscreen Bar | TITANIUM DIOXIDE, ZINC OXIDE | BB MEDICAL & DERMATOLOGY INC | 342b69d5-f0e1-99cd-e063-6294a90abb6e | 2025-12-10 | M020 | |
| Sheer Facial Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | BB MEDICAL & DERMATOLOGY INC | 342c3f42-c17f-f777-e063-6394a90a8058 | 2025-12-10 | M020 | |
| Lip SPF | TITANIUM DIOXIDE, ZINC OXIDE | FRANCISCO FLORES, M.D., P.A. | 396d3fdd-99d8-77e8-e063-6294a90aec2f | 2025-12-10 | M020 | |
| Non-Tinted Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | FRANCISCO FLORES, M.D., P.A. | 396cae82-7641-e1b2-e063-6394a90a7c07 | 2025-12-10 | M020 | |
| Solar Knight SPF 40 Broad Spectrum | TITANIUM DIOXIDE, ZINC OXIDE | MASCARENAS ENTERPRISES, INC. | 36c27c91-22ac-205c-e063-6294a90ab379 | 2025-12-10 | M020 | |
| Tinted Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | FRANCISCO FLORES, M.D., P.A. | 396ce15a-06ad-4055-e063-6294a90a27fb | 2025-12-10 | M020 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 62032-612-04 | 62032061204 | 148 mL in 1 BOTTLE, PLASTIC | 148 ml | Historical | ||||
| 62032-811-09 | 62032081109 | 1 in 1 CARTON | Historical | |||||
| 62032-909-09 | 62032090909 | 1 KIT in 1 BOX (62032-909-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC | 1 kit | 2021-08-01 | 0000-00-00 | No | No | Current |